MedMemos: helping families stick to medications after pediatric stem cell transplant
Official title: MedMemos: An Intervention to Promote Medication Adherence in Pediatric Allogenic Hematopoietic Stem Cell Transplantation
Run by Nationwide Children's Hospital · NCT07718204 · Data updated 2026-11-12
MedMemos tests a caregiver-focused program to help families of children who had a bone marrow transplant take medications more consistently.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Years to 12 Years |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Nationwide Children's Hospital Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | July 21, 2026 |
| Trial ID | NCT07718204 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 0-12 who had a pediatric allogeneic hematopoietic cell transplant and are still in the hospital at enrollment, with a primary caregiver who can participate and administer oral medications.
✕Probably not a fit
Caregivers or children who do not speak English, Spanish, or Arabic, or those unable to use an electronic medication monitor, may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests the MedMemos intervention designed for parents and their children who received a pediatric hematopoietic cell transplant. Participants will complete surveys, participate in four sessions, and use an electronic device to track and store medications. The goal is to see whether the program is acceptable, feasible, and able to improve medication adherence. The study focuses on caregivers of children ages 0-12 who are in the hospital at discharge and prescribed oral medications.
Why it matters
Potential benefit: If successful, the program could make it easier for families to manage complex medication regimens after transplant.
How similar studies have gone: Prior similar efforts in medication adherence for pediatric transplant care have shown feasibility; this study assesses acceptability and proof-of-concept for MedMemos.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Child had a Pediatric Allogeneic Hematopoietic Cell Transplant (PAHCT) * Child is 0-12 years of age * At the time of recruitment child is still in the hospital for PAHCT * Child's primary caregiver is responsible for administering medical care and is willing to give consent to participate * Child is prescribed an oral medication regimen at discharge Exclusion Criteria: * Caregiver does not speak English, Spanish, or Arabic * Caregiver is not available to provide written permission for the child's participation * EMR or medical team report of the caregiver's cognitive status precludes completion of questionnaires * The child's medical status or condition precludes completion of the study questionnaires as determined by the physician or caregiver * Caregiver is unwilling to store medication in an electronic monitor
Where it's running
-
Nationwide Children's Hospital
Columbus, Ohio, United States Recruiting
Study contacts
- Study coordinator: Ahna LH Pai, PhD
- Email: Ahna.Pai@nationwidechildrens.org
- Phone: (614) 938-1601
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
BFCA conditioning for Haplo-HSCT in older adults with severe aplastic anemia
This study tests the BFCA conditioning regimen in adults aged 40–60 with severe aplastic anemia undergoing haploidentical stem cell transplant to see if it’s safe and effective.
-
Early tacrolimus in HLA-mismatched haploidentical blood stem-cell transplant with post-transplant cyclophosphamide
This trial tests whether starting tacrolimus earlier, together with post-transplant cyclophosphamide and mycophenolate, can reduce cytokine release syndrome in people receiving HLA-mismatched haploidentical peripheral blood stem-cell transplants.
-
Primary palliative care for people undergoing stem cell transplant
We will try training transplant clinicians to provide basic palliative care during hospital stays to see if it works and is acceptable for adults having stem cell transplants.
-
Optimizing Letermovir Prophylaxis for Hematopoietic Cell Transplant Recipients
This study is testing if stopping a medication for preventing CMV infections based on a patient's immune response can help hematopoietic cell transplant recipients stay healthier and avoid infections.
-
Understanding respiratory viral infections in pediatric transplant recipients
This study is trying to see if measuring respiratory viruses before a transplant can help predict which kids might get respiratory infections afterward.
-
Cognitive training program for survivors of hematopoietic cell transplantation
This study is testing a brain training program to see if it can help people who have survived hematopoietic cell transplantation think better and improve their memory over 12 weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.